CSIMarket
 


Vigil Neuroscience Inc   (VIGL)
Other Ticker:  
 

Cumulative Vigil Neuroscience Inc 's Leverage Ratio for Trailing Twelve Months Period

VIGL's Leverage Ratio for Trailing Twelve Months Period and Total Liabilities, Equity growth


Select the Comparisons : Select the Ratio:

VIGL Leverage Ratio for Trailing Twelve Months Period

(Sep 30 2023)
III. Quarter
(Jun 30 2023)
II. Quarter
(Mar 31 2023)
I. Quarter
(Dec 31 2022)
IV. Quarter
(Sep 30 2022)
III. Quarter
Y / Y Equity Growth -34.03 % 2.13 % 3.11 % - -
Y / Y Total Liabilities Growth 886.88 % 195.44 % 216.87 % - -
Leverage Ratio for Trailing Twelve Months Period 0.1 0.07 0.05 0.03 0.03
Total Ranking # 206 # 155 # 120 # 74 #
Seq. Equity Growth -11.7 % -10.22 % -9.38 % -8.17 % 36.7 %
Seq. Total Liabilities Growth 8.1 % 2.63 % 982.44 % -17.82 % -67.64 %


Leverage Ratio for Trailing Twelve Months Period Comment for 12 Months ending at Sep 30 2023
On the trailing twelve months basis Due to net new borrowings of 8.1%, Leverage Ratio for Trailing Twelve Months Period improved to 0.1, above Vigil Neuroscience Inc 's average Leverage Ratio for Trailing Twelve Months Period.
Leverage Ratio for Trailing Twelve Months Period is the average cumulative value over the last four quarters.

Among companies in Biotechnology & Pharmaceuticals industry 29 other companies have achieved lower Leverage Ratio for Trailing Twelve Months Period than Vigil Neuroscience Inc . While total ranking remained unchanged compare to previous quarter at no. .

What is Leverage Ratio?
Who are VIGL's Customers?
Leverage Ratio for Trailing Twelve Months Period Company Ranking
Within: No.
Industry # 30
Sector # 192
S&P 500 # 343


Leverage Ratio for Trailing Twelve Months Period Statistics
High Average Low
0.12 0.08 0.05
(Sep 30 2023)   (Dec 31 2022)




Companies with similar average Leverage Ratio for Trailing Twelve Months Period for 12 months ending Sep 30 2023, within Biotechnology & Pharmaceuticals Industry Leverage Ratio for Trailing Twelve Months Period
Monte Rosa Therapeutics Inc   0.28 
Sophia Genetics Sa  0.28 
Instil Bio Inc   0.28 
Voyager Therapeutics Inc   0.28 
Fresh Tracks Therapeutics Inc   0.27 
Vir Biotechnology Inc   0.27 
Denali Therapeutics Inc   0.26 
Solid Biosciences Inc   0.26 
Passage Bio inc   0.25 
Bio techne Corp  0.24 
Exelixis Inc   0.23 
Iovance Biotherapeutics Inc   0.23 
Twist Bioscience Corporation  0.23 
Vor Biopharma Inc   0.22 
Caribou Biosciences Inc   0.22 
Allogene Therapeutics inc   0.22 
Allovir Inc   0.22 
Adverum Biotechnologies Inc   0.22 
Tarsus Pharmaceuticals Inc   0.22 
Dyadic International Inc  0.22 
Ocugen Inc   0.21 
Dbv Technologies S a   0.21 
Hillevax Inc   0.21 
Crispr Therapeutics Ag  0.20 
Bioatla Inc   0.20 
Palisade Bio Inc   0.20 
Compugen Ltd  0.20 
Cardiol Therapeutics inc   0.19 
Jasper Therapeutics Inc   0.19 
Jounce Therapeutics inc   0.19 




Help

About us

Advertise

CSIMarket Company, Sector, Industry, Market Analysis, Stock Quotes, Earnings, Economy, News and Research. 
   Copyright © 2024 CSIMarket, Inc. All rights reserved. This site uses cookies to make your browsing experince better. By using this site, you agree to the Terms of Service and Privacy Policy - UPDATED (Read about our Privacy Policy)

Intraday data delayed per exchange requirements. All quotes are in local exchange time. Intraday data delayed 15 minutes for Nasdaq, and other exchanges. Fundamental and financial data for Stocks, Sector, Industry, and Economic Indicators provided by CSIMarket.com